These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 25363411)

  • 1. In silico study combining docking and QSAR methods on a series of matrix metalloproteinase 13 inhibitors.
    Xi L; Li S; Yao X; Wei Y; Li J; Liu H; Wu X
    Arch Pharm (Weinheim); 2014 Nov; 347(11):825-33. PubMed ID: 25363411
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potent inhibitors precise to S1' loop of MMP-13, a crucial target for osteoarthritis.
    Kalva S; Saranyah K; Suganya PR; Nisha M; Saleena LM
    J Mol Graph Model; 2013 Jul; 44():297-310. PubMed ID: 23938376
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A study on quantitative structure-activity relationship and molecular docking of metalloproteinase inhibitors based on L-tyrosine scaffold.
    Abbasi M; Ramezani F; Elyasi M; Sadeghi-Aliabadi H; Amanlou M
    Daru; 2015 Apr; 23(1):29. PubMed ID: 25925871
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A combined molecular modeling study on gelatinases and their potent inhibitors.
    Xi L; Du J; Li S; Li J; Liu H; Yao X
    J Comput Chem; 2010 Jan; 31(1):24-42. PubMed ID: 19412908
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Robust design of some selective matrix metalloproteinase-2 inhibitors over matrix metalloproteinase-9 through in silico/fragment-based lead identification and de novo lead modification: Syntheses and biological assays.
    Adhikari N; Halder AK; Mallick S; Saha A; Saha KD; Jha T
    Bioorg Med Chem; 2016 Sep; 24(18):4291-4309. PubMed ID: 27452283
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rational prediction of the herbicidal activities of novel protoporphyrinogen oxidase inhibitors by quantitative structure-activity relationship model based on docking-guided active conformation.
    Lei B; Li J; Lu J; Du J; Liu H; Yao X
    J Agric Food Chem; 2009 Oct; 57(20):9593-8. PubMed ID: 19780536
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Application of GA-MLR for QSAR Modeling of the Arylthioindole Class of Tubulin Polymerization Inhibitors as Anticancer Agents.
    Ahmadi S; Habibpour E
    Anticancer Agents Med Chem; 2017; 17(4):552-565. PubMed ID: 27528182
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sulfonamide derivatives containing dihydropyrazole moieties selectively and potently inhibit MMP-2/MMP-9: Design, synthesis, inhibitory activity and 3D-QSAR analysis.
    Yan XQ; Wang ZC; Li Z; Wang PF; Qiu HY; Chen LW; Lu XY; Lv PC; Zhu HL
    Bioorg Med Chem Lett; 2015 Oct; 25(20):4664-71. PubMed ID: 26346367
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiple receptor-ligand based pharmacophore modeling and molecular docking to screen the selective inhibitors of matrix metalloproteinase-9 from natural products.
    Gao Q; Wang Y; Hou J; Yao Q; Zhang J
    J Comput Aided Mol Des; 2017 Jul; 31(7):625-641. PubMed ID: 28623487
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of selective MMP-9 inhibitors through multiple e-pharmacophore, ligand-based pharmacophore, molecular docking, and density functional theory approaches.
    Jana S; Singh SK
    J Biomol Struct Dyn; 2019 Mar; 37(4):944-965. PubMed ID: 29475408
    [TBL] [Abstract][Full Text] [Related]  

  • 11. QSAR based docking studies of marine algal anticancer compounds as inhibitors of protein kinase B (PKBβ).
    Davis GD; Vasanthi AH
    Eur J Pharm Sci; 2015 Aug; 76():110-8. PubMed ID: 25936945
    [TBL] [Abstract][Full Text] [Related]  

  • 12. QSAR modeling of matrix metalloproteinase inhibition by N-hydroxy-alpha-phenylsulfonylacetamide derivatives.
    Fernández M; Caballero J
    Bioorg Med Chem; 2007 Sep; 15(18):6298-310. PubMed ID: 17590339
    [TBL] [Abstract][Full Text] [Related]  

  • 13. QSAR study of carboxylic acid derivatives as HIV-1 Integrase inhibitors.
    Cheng Z; Zhang Y; Fu W
    Eur J Med Chem; 2010 Sep; 45(9):3970-80. PubMed ID: 20561721
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular Recognition of the Catalytic Zinc(II) Ion in MMP-13: Structure-Based Evolution of an Allosteric Inhibitor to Dual Binding Mode Inhibitors with Improved Lipophilic Ligand Efficiencies.
    Fischer T; Riedl R
    Int J Mol Sci; 2016 Mar; 17(3):314. PubMed ID: 26938528
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Constructing and Validating 3D-pharmacophore Models to a Set of MMP-9 Inhibitors for Designing Novel Anti-melanoma Agents.
    Medeiros Turra K; Pineda Rivelli D; Berlanga de Moraes Barros S; Mesquita Pasqualoto KF
    Mol Inform; 2016 Jul; 35(6-7):238-52. PubMed ID: 27492238
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A QSAR study on the inhibition mechanism of matrix metalloproteinase-12 by arylsulfone analogs based on molecular orbital calculations.
    Hitaoka S; Chuman H; Yoshizawa K
    Org Biomol Chem; 2015 Jan; 13(3):793-806. PubMed ID: 25406681
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Virtual Screening on MMP-13 Led to Discovering New Inhibitors Including a Non-Zinc Binding and a Micro Molar One: A Successful Example of Receptor Selection According to Cross-Docking Results for a Flexible Enzyme.
    Ramezani M; Shamsara J
    Comb Chem High Throughput Screen; 2017; 20(8):719-725. PubMed ID: 28814230
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exploring QSAR and pharmacophore mapping of structurally diverse selective matrix metalloproteinase-2 inhibitors.
    Halder AK; Saha A; Jha T
    J Pharm Pharmacol; 2013 Oct; 65(10):1541-54. PubMed ID: 24028622
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure-based design and optimization of pyrimidine- and 1,2,4-triazolo[4,3-a]pyrimidine-based matrix metalloproteinase-10/13 inhibitors via Dimroth rearrangement towards targeted polypharmacology.
    El Ashry ESH; Awad LF; Teleb M; Ibrahim NA; Abu-Serie MM; Abd Al Moaty MN
    Bioorg Chem; 2020 Mar; 96():103616. PubMed ID: 32032847
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure-based quantitative structure-activity relationship studies of checkpoint kinase 1 inhibitors.
    Du J; Xi L; Lei B; Lu J; Li J; Liu H; Yao X
    J Comput Chem; 2010 Nov; 31(15):2783-93. PubMed ID: 20839304
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.